Trial intelligence / Profile preview

Qinghua Quyu Prescription Rectal Instillation for Ulcerative Colitis

NCT05780723Completed

Sponsor
Beijing Hospital of Traditional Chinese Medicine
Start
Apr 2023
Primary completion
Oct 2024
Modality
HM (Herbal Medicine)
Countries
1
01

Overview

Randomised trial of qinghua quyu in ulcerative colitis (UC) (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: Modified Mayo Activity Index at 8 weeks. Started Apr 2023; status: completed.

02

Drugs

qinghua quyu
03

Conditions

ulcerative colitis (UC)

Beyond the preview

Go deeper on NCT05780723.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05780723.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call